Safety and efficacy of once-weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes over 84 weeks (Q41831179)

From Wikidata
Jump to navigation Jump to search
scientific article published on 22 February 2012
edit
Language Label Description Also known as
English
Safety and efficacy of once-weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes over 84 weeks
scientific article published on 22 February 2012

    Statements

    Safety and efficacy of once-weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes over 84 weeks (English)
    1 reference
    Luc Van Gaal
    1 reference
    Stephen Stranks
    1 reference
    Bruno Guerci
    1 reference
    Leigh MacConell
    1 reference
    Harry Haber
    1 reference
    Jamie Scism-Bacon
    1 reference
    Michael Trautmann
    1 reference
    22 February 2012
    1 reference
    35
    1 reference
    683-689
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit